Form 4: Accolade Inc. President Reports Stock Transactions
SEC Form 4 Filing
Robert N. Cavanaugh, President of Accolade, Inc., reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On October 10, 2024, Robert N. Cavanaugh, President of Accolade, Inc., acquired 710 shares of common stock through the conversion of Restricted Stock Units (RSUs).
- On October 11, 2024, Cavanaugh disposed of 217 shares of common stock at a price of $3.771 per share to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Cavanaugh directly owns 197,202 shares of Accolade, Inc. common stock and 5,685 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions related to executive compensation and tax obligations.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key executives and their potential impact on the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
- Similar filings are made by executives at companies like Teladoc Health and Livongo, providing insights into their stock ownership and trading activities.
- The reported transactions are typical for executives receiving stock-based compensation and managing their tax obligations.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
- The filing provides transparency to shareholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| June 10, 2022 | June 2022 RSU Vesting Commencement Date |
| October 10, 2024 | Acquisition of 710 shares of common stock through RSU conversion |
| October 11, 2024 | Disposal of 217 shares of common stock at $3.771 per share |
| October 15, 2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.